Scholarship Announcement 2020 – BEST THESIS IN HEALTH ECONOMICS2 Apr 2020

The Swedish Institute for Health Economics and the Bengt Jönsson…

https://ihe.se/en/2020/04/02/scholarship-announcement-2020-best-thesis-in-health-economics/

New IHE Report on patient pathways in the treatment of opioid drug dependency6 Mar 2020

In this report, the Swedish Institute for Health Economics analyses…

https://ihe.se/en/2020/03/06/new-ihe-report-on-patient-pathways-in-the-treatment-of-opioid-drug-dependency/

New IHE publication reviews the use of risk sharing agreements in Sweden4 Mar 2020

In 2014 managed entry agreements (MEA) between Swedish health care…

https://ihe.se/en/2020/03/04/new-ihe-publication-reviews-the-use-of-risk-sharing-agreements-in-sweden/

New IHE publication shows that cancer causes costs of €199 billion in Europe4 Mar 2020

A new IHE publication in the European Journal of Cancer…

https://ihe.se/en/2020/03/04/new-ihe-publication-shows-that-cancer-causes-costs-of-e199-billion-in-europe/

Doctoral thesis2 Mar 2020

 Sara Olofsson, research manager at IHE, presented her dissertation ‘The…

https://ihe.se/en/2020/03/02/doctoral-thesis-3/

EU launch event of IHE’s Comparator report on cancer24 Jan 2020

Next week (29 January) Thomas Hofmarcher will present the main…

https://ihe.se/en/2020/01/24/eu-launch-event-of-ihes-comparator-report-on-cancer/

Staff News17 Jan 2020

The Swedish Institute for Health Economics welcomes George Keel and…

https://ihe.se/en/2020/01/17/staff-news/

New IHE Comparator Report on cancer in Europe16 Jan 2020

In a new report, IHE analyzes and compares the cancer…

https://ihe.se/en/2020/01/16/new-ihe-comparator-report-on-cancer-in-europe/

Health-economic modelling without direct cardioprotective effects substantially underestimates the benefits of new classes of diabetes drugs5 Nov 2019

People with type 2 diabetes mellitus (T2DM) have an increased…

https://ihe.se/en/2019/11/05/health-economic-modelling-without-direct-cardioprotective-effects-substantially-underestimates-the-benefits-of-new-classes-of-diabetes-drugs/

Risk Factor Clustering and the Economic Modeling of T2DM5 Nov 2019

Microsimulation using risk equations to convert biomarker values into event…

https://ihe.se/en/2019/11/05/risk-factor-clustering-and-the-economic-modeling-of-t2dm-2/